Temporal Cre-mediated recombination exclusively in endothelial cells using Tie2 regulatory elements.
The versatility of the bacteriophage Cre/LoxP system is dependent on the availability of a spectrum of tissue-specific Cre transgenic mice to address a host of biological questions. In this paper, we report on the generation of an inducible Tie2Cre transgenic mouse line that facilitates gene targeting exclusively in endothelial cells. The temporal manner of recombination is feasible through the use of a Cre-estrogen receptor fusion protein ER(T2) and was, in practical terms, achieved by feeding the animals the estrogen antagonist tamoxifen orally for 5 weeks. High efficiency of recombination was found in the vast majority of endothelial cell populations examined, as monitored by an EGFP reporter mouse line. Critically, no EGFP expression was observed in any uninduced mice. This inducible Cre line will be a very beneficial asset to investigating the role of endothelial specific genes in the adult mouse and to induce transgenes in the endothelium in an extremely efficient manner. genesis 33:191-197, 2002.
Department of Molecular Immunology, Division of Tumor Immunology, German Cancer Research Center, Heidelberg, Germany.
Anne
A
Forde
Rainer
R
Constien
Hermann-Josef
HJ
Gröne
Günter
G
Hämmerling
Bernd
B
Arnold
D000818:Animals; D002478:Cells, Cultured; D004730:Endothelium, Vascular / Q000502:physiology*; D005809:Genes, Regulator; D019426:Integrases / Q000235:genetics*; D051379:Mice; D008822:Mice, Transgenic; D020794:Receptor Protein-Tyrosine Kinases / Q000235:genetics*; D042787:Receptor, TIE-2; D011993:Recombinant Fusion Proteins; D011995:Recombination, Genetic / Q000502:physiology*; D014764:Viral Proteins / Q000235:genetics*
D011993:Recombinant Fusion Proteins; D014764:Viral Proteins; D020794:Receptor Protein-Tyrosine Kinases; D042787:Receptor, TIE-2; C045073:Cre recombinase; D019426:Integrases